Liminatus Pharma LIMN 深 滬
等待開盤 08-21 09:30:00 美东时间
0.1126
+0.001
+0.81%
華盛通- 最 高0.1189
- 今 開0.1138
- 成交量 357.74万股
- 最 低 0.1079
- 昨 收 0.1117
- 總市值 756.23万
- 52周最高 3.09
- 市盈率 靜 --
- 換手率 5.33%
- 52周最低 0.095
- 委 比 75.75%
- 總股本 6716.04万
- 歷史最高 33.66
- 量 比 0.03
- 振 幅 9.85%
- 歷史最低 0.095
- 每 手 1
- 風險率 0.78%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Liminatus Pharma shares are trading higher after the company announced its stock transfer to the Nasdaq Capital Market and an extension to meet minimum bid price compliance.
Liminatus Pharma shares are trading higher after the company announced its stock transfer to the Nasdaq Capital Market and an extension to meet minimum bid price compliance.
08-14 02:58
Liminatus Pharma Shareholders Approve Reverse Stock Split Plan
An announcement from Liminatus Pharma ( ($LIMN) ) is now available. On August 3...
08-05 05:37
11 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Chemomab Therapeutics (NASDAQ:CMMB) stock increased by 33.8% to $2.27 during Thursday's regular session. The market value of their outstanding shares is at $12.2 million. Liminatus Pharma (NASDAQ:LIMN) shares rose 26.04% to $0.14. The market value of their outstanding shares is at $5.8 milli...
07-03 01:05
Liminatus Pharma Amends Proposed $320M Merger Deal With InnocsAI As Closing Now Anticipated Before Shareholder Approval On July 2
Liminatus Pharma, Inc. (Nasdaq: LIMN) ("Liminatus" or the "Company"), a biotechnology company developing innovative cancer therapies, today announced that it has amended and restated the previously announced definitive merger agreement with InnocsAI LLC ("InnocsAI"), an oncology biotechnology compan...
07-01 04:32
Liminatus Pharma secures $1.9M cash via warrant exercises
Liminatus Pharma (LIMN) has entered into a warrant exercise agreement to exercise certain outstanding warrants to purchase an aggregate of 10.34M shares of common stock of the company for gross procee...
06-03 21:14
Liminatus Pharma Enters Warrant Exercise Agreement With Existing Investors To Purchase 10,344,000 Shares At $0.18 Per Share
In consideration for the immediate exercise of the Existing Warrants for cash, the exercising holders were issued new unregistered warrants to purchase an aggregate of 20,688,000 million shares of common stock (the "New
06-03 20:33
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Akari Therapeutics (NASDAQ:AKTX) stock increased by 40.3% to $7.21 dur...
05-22 05:06
Liminatus Pharma Announces Nasdaq Delisting Notification
Liminatus Pharma, Inc. received a delisting notice from Nasdaq as it failed to meet the $50 million market value of listed securities and $15 million market value of publicly held shares requirements. The company had 180 days to regain compliance but did not meet the criteria by May 18, 2026. Trading of its securities will be suspended on May 29, 2026, unless an appeal is filed by May 27, 2026. The company intends to request an appeal to delay de...
05-22 00:28
